Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;86(10):1921-1930.
doi: 10.1111/bcp.14094. Epub 2019 Dec 16.

Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions

Affiliations
Review

Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions

A Clara Drenth-van Maanen et al. Br J Clin Pharmacol. 2020 Oct.

Abstract

Ageing is associated with several changes in human organs, which result in altered medication pharmacokinetics and pharmacodynamics. Ageing is also associated with changes in human body functions, such as impaired vision, hearing, swallowing, motor and cognitive functions, which can affect the adequate intake and administration of drugs. As a consequence, older people, and especially patients older than 75 years, are the main users of many drugs and they frequently use 5 drugs or more long-term (i.e. polypharmacy). All this increases the complexity of adequate drug intake, administration and adherence. However, there is a lack of evidence on the considerations that should be taken into account to ensure appropriate drug prescribing to older people. This review article summarizes the most clinically relevant changes in human organ and body functions and the consequential changes in pharmacokinetics and pharmacodynamics in older people, along with possible dosing consequences or alternatives for drugs frequently prescribed to this patient population. Recommendations are given on how ageing could be considered in clinical drug development, drug authorization and appropriate prescribing.

Keywords: drug authorization; impaired organ function; older people; pharmacodynamics; pharmacokinetics; pharmacotherapy.

PubMed Disclaimer

References

    1. who.int [homepage on the internet] . WHO factfiles ageing. []. Available from https://www.who.int/features/factfiles/ageing/en/. Accessed August 12, 2019.
    1. ec.europa.eu/commission/index_en [homepage on the internet] . European Commission and Employment, social affairs and inclusion. Active Ageing. 2015. Available from https://ec.europa.eu/social/main.jsp?catId=1062&langId=en. Accessed August 12, 2019.
    1. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392‐397. - PMC - PubMed
    1. Jansen PA, Brouwers JR. Clinical pharmacology in old persons. Scientifica (Cairo). 2012;2012:723678. - PMC - PubMed
    1. Sera LC, McPherson ML. Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clin Geriatr Med. 2012;28:273‐286. - PubMed

Substances